Introduction
Functional capacity and ventilatory effi ciency assessed by cardiopulmonary exercise testing (CPET) are of established value in patients with chronic heart failure (CHF) due to left ventricular systolic dysfunction (LVDS) 1, 2 . Functional capacity is generally determined by peak oxygen consumption (pVO 2 ), while assessment of ventilatory effi ciency is based on analysis of the relationship between minute ventilation (VE) and carbon dioxide (CO 2 ) production -VE/VCO 2 -or ventilatory equivalent for CO 2 , in practice the amount of air needed to eliminate one liter of CO 2 .
There are multiple determinants of functional capacity, particularly the interaction between pulmonary, cardiac and skeletal muscle function, as well as age, gender, muscle mass and conditioning status 1 . Despite this dependence on multiple factors, in fit individuals without pulmonary or skeletal muscle disease, pVO 2 provides an indirect measure of cardiac output (CO), the correlation being determined by established formulas 1, 3, 4 .
Although the most important determinant of ventilatory efficiency is the correlation between ventilation and perfusion 2 , the mechanisms that lead to reduced effi ciency in CHF patients remain the subject of debate 5 .
Thoracic electrical bioimpedance (TEB) was developed in the 1960s as part of NASA's space program 6 , as a non-invasive technique for continuous hemodynamic monitoring. It is based on the use of a high-frequency, low-amplitude electric current to calculate impedance of the fl ow of electricity through the chest. It measures instantaneous beat-by-beat changes in electrical impedance, on the basis of which algorithms have been developed to calculate parameters such as systolic volume, CO and thoracic fluid content (TFC), among others. The latest generation TEB systems are being used more widely following studies confi rming their effi cacy in various pathologies and correlation with invasive measurements [7] [8] [9] .
TFC, a new parameter assessed non-invasively by TEB, is an indicator of total chest fl uid volume, both intra-and extracellular, particularly in the lungs 10 . In the absence of significant pleural and/or pericardial effusion, it can be used as an indirect measure of pulmonary perfusion.
Objective
The aim of this study was to investigate the possible correlation between parameters of ventilatory effi ciency obtained by CPET and TFC assessed by TEB, in patients with CHF due to LVSD.
Methods
We studied 120 patients with LVSD and CHF, 91 (76%) male, 76 (63%) of non-ischemic and 44 (37%) of ischemic etiology, referred to our laboratory for a fi rst CPET.
Only patients with left ventricular ejection fraction (LVEF) ≤40% on echocardiographic study in the previous 30 days were included; patients in New York Heart Association (NYHA) functional class IV and those with diseases that limited their ability to exercise or with moderate to severe lung, kidney or liver disease were also excluded. The presence of moderate or severe lung disease was assessed mainly through clinical history, observation and chest X-ray; only 24 patients (20%) underwent spirometry, which showed no signifi cant alterations.
The patients' mean age was 52.1±12.1 years (21-77), body mass index 26.4±4.1 kg/m 2 (17.6-37.6), left ventricular (LV) end-diastolic dimension 39.5±5.8 mm/m 2 (31.9-57.0) and echocardiographic LVEF 27.5±8.0% (10-40%), and 83% were in sinus rhythm. According to the records of the physicians referring for CPET, 80.8% of the patients were in NYHA functional class ≤II. Mean serum creatinine was 1.10±0.40 mg/dl (0.6-2.0), hemoglobin 13.7±1.5 g/ dl (10.9-17.5), and NT-proBNP 2163.5±2387.8 pg/ml (54.8-10,924.0). With regard to medication, 96% were taking angiotensin-converting enzyme inhibitors and/ or angiotensin receptor blockers, 89% furosemide and/ or thiazide, 79% beta-blockers, 68% spironolactone, and 45% digoxin, and 20% were treated with a cardiac resynchronization device. The characteristics of the study population are summarized in Table. CPET methodology Patients underwent symptom-limited maximal CPET on a computerized treadmill using the modifi ed Bruce protocol. A SensorMedics Vmax 229 system (Yorba Linda, Calif.) was used for analysis of respiratory gases and continuous 12-lead electrocardiographic monitoring. The equipment was calibrated before each test. Collection and analysis of respiratory gases was begun three minutes before exercise with the patient in a standing position and was continued until the sixth minute of recovery, as was ECG monitoring. Blood pressure was measured at rest, before each increment, at peak exercise, and at the fi rst, third and sixth minute of recovery. VO 2 , VCO 2 and VE were assessed breath-by-breath, with pVO 2 calculated as the mean of the last 30 seconds of the test. The VE/VCO 2 slope was calculated by the system's computer.
The patients were encouraged to continue until the VCO 2 / VO 2 ratio (respiratory quotient) was ≥1.09. The anaerobic threshold (AT), determined using the V-slope method and corrected when necessary using the ventilatory equivalent for O 2 , was achieved by all patients.
In no case did blood pressure changes, arrhythmia, angina or ECG alterations prompt interruption of the test in accordance with the criteria stipulated in international guidelines 11 , and thus all exams were terminated due to fatigue or dyspnea as perceived by the patient.
The patients' usual medication was not suspended before the test.
We analyzed pVO 2 (ml/kg/min) and, as ventilatory effi ciency parameters, VE/VCO 2 slope and VE/VCO 2 at AT.
TEB methodology
TEB studies (BioZ ® ICG Monitor, CardioDynamics) were performed immediately prior to CPET, with the patient in dorsal decubitus and the sensors placed on the neck and lateral chest wall. The mean acquisition time was 20 minutes.
In the present study, the value of TFC (kOhm -1 ) was considered for the analysis.
No patient presented pleural or pericardial effusion (as assessed by clinical history, chest X-ray and echocardiography), which would infl uence assessment of TFC, or more than mild aortic regurgitation, which would invalidate assessment by TEB.
Statistical analysis
The results for the variables under analysis are presented as means ±1 standard deviation (SD) and medians. Correlations between variables were tested using Pearson's correlation coefficient since they presented a normal distribution. A value of p <0.05 was considered statistically signifi cant. The coeffi cient of determination (r 2 ) was calculated for the results obtained.
Receiver operating characteristic (ROC) curves were constructed based on the logistic regression models to assess the quality of the correlations by calculating the area under the curve (AUC) and to determine the TFC cut-off for the CPET parameters analyzed.
Results
TFC ranged between 20.6 and 45.8 kOhm −1 , mean 32.2, SD 5.7, median 32.7. The values for the CPET parameters analyzed were: pVO 2 8.9-40.6 ml/kg/min, mean 21.0, SD 6.2, median 20.2; VE/VCO 2 slope 19.8-60.7, mean 30.7, SD 7.9, median 29.1; and VE/VCO 2 at AT 21-62, mean 33.1, SD 7.5, median 31.5.
By linear regression, there was a strong correlation between CPET parameters: pVO 2 and VE/VCO 2 slope -r=0.64, p <0.001; pVO 2 and VE/VCO 2 at AT -r=0.66, p <0.001; and VE/VCO 2 slope and VE/VCO 2 at AT -r=0.88, p <0.001.
TFC did not correlate with pVO 2 (r=0.05, p=0.58), but showed correlation with parameters of ventilatory effi ciency: r=0.20, p=0.032, r 2 =0.04 for VE/VCO 2 slope and r=0.25, p=0.009, r 2 =0.06 for VE/VCO 2 at AT (Figure 1) .
ROC curves were used to assess the quality of the correlations between TFC determined by TEB and ventilatory parameters by CPET. For VE/VCO 2 slope ≥34, the AUC was 0.70, with 95% confi dence interval (CI) of 0.59-0.81 ( Figure 2 ). TFC >35.9 had sensitivity of 60% and specifi city of 80% for VE/VCO 2 ≥34. For VE/VCO 2 at AT ≥34, the AUC was 0.74, with 95% CI of 0.65-0.84 (Figure 2 ). TFC >34.9 had sensitivity of 65% and specificity of 84% for VE/VCO 2 at AT ≥34.
Discussion
The present study found a correlation, albeit of low statistical significance, between resting TFC and CPET parameters assessing ventilatory effi ciency. TFC can be used as an indirect measure of pulmonary perfusion; a previous study by our group established a significant correlation between TFC and pulmonary capillary wedge pressure (PCWP) 9 . These results are in agreement with those of Reindl et al. 12 , who demonstrated a positive correlation between resting PCWP and pulmonary artery pressure and VE/VCO 2 slope.
Lewis et al. 5 also found a signifi cant correlation between resting PCWP and VE/VCO 2 slope. Chronically elevated left ventricular fi lling pressures may contribute to inadequate pulmonary vasodilation and a high dead space-to-tidal volume ratio (V D /V T ) during exercise through pulmonary vascular remodeling. On the other hand, no correlation was seen between VE/VCO 2 slope and PCWP during exercise, suggesting that ventilatory efficiency is not dictated simply by acute changes in left ventricular fi lling pressures during exercise; for these authors, changes in pulmonary vasomotor tone and right ventricular function may also be important determinants of ventilatory effi ciency in patients with CHF. The role of muscle ergoreceptor overactivity in hyperventilation during exercise in CHF patients has also been investigated [13] [14] [15] . The ergorefl ex, which is heightened in these patients, is a complex metabolic refl ex in which peripheral chemoreceptors in muscle react to local metabolic byproducts during exercise and initiate a neural refl ex that drives hyperventilation 5 . Although the relative contribution of the ergorefl ex to this phenomenon remains to be fully clarifi ed, Guazzi et al. 16 have demonstrated that long-term use of sildenafi l in CHF patients attenuates this refl ex and improves VE/VCO 2 slope.
To summarize, many different factors determine ventilatory effi ciency in patients with CHF. The present study demonstrated that it correlates with TFC as assessed by TEB, and we postulate that the value of this new parameter is not restricted to its correlation with PCWP. TFC, a measure of the total volume of chest fl uids, both extra-and intracellular, provides better and more reliable assessment of changes than traditional hemodynamic parameters 10 . Okawa et al., in a study of patients with acute myocardial infarction, also found a significant correlation between TFC and PCWP, which was independent of cardiac index 17 . However, their results suggest that TFC is a better predictor of the degree of pulmonary congestion, particularly when PCWP is <18 mmHg.
Our aim was to investigate the possible correlation between TFC assessed by TEB and parameters of ventilatory effi ciency determined by CPET. However, we also analyzed pVO 2 , and in the TEB studies performed prior to CPET, cardiac output was also determined. While as expected, pVO 2 presented a strong correlation with ventilatory efficiency parameters, no significant correlation was found with TFC, suggesting that this is not a determinant of pVO 2 . Resting CO assessed by TEB showed a mean value of 4.5±1.2 l/min (1.9-8.1). No signifi cant correlation was found between CO and TFC (r=0.156, p=0.10), nor with VE/ VCO 2 slope (r=0.169, p=0.07) or VE/VCO 2 at AT (r=0.118, p=0.23), the correlation being significant only with pVO 2 (r=0.208, p=0.023). While not within the scope of the present study, these results support the idea that CO, even assessed at rest, is a determinant of pVO 2 1,3,4 . Most studies investigating correlations between hemodynamic parameters, obtained either invasively or non-invasively, and functional capacity and ventilatory effi ciency assessed by CPET, have been based on analysis of hemodynamic parameters at rest. Interestingly, when these parameters are assessed during exercise, either they do not correlate with CPET variables (with the exception of pVO 2 and CO) 5 , or they provide no additional prognostic value 1 . This surprising fi nding may be explained by the fact that there are multiple determinants of CPET parameters, including cardiac reserve and skeletal muscle, pulmonary and endothelial (dys)function. The correlation between ventilatory efficiency determined by VE/VCO 2 slope and hemodynamic variables assessed at rest would appear less controversial, since it is constant at submaximal exercise.
The main limitations of the present study are that spirometry was not performed and that changes in TFC during exercise were not assessed.
Conclusion
Thoracic fluid content determined by thoracic electrical bioimpedance correlates with CPET parameters of ventilatory effi ciency in patients with congestive heart failure due to left ventricular systolic dysfunction, suggesting that it may be one of its determinants.
